跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,353 条关于
“BBS”
全部
3,353
临床试验
2,396
药物
778
机构
10
资讯
169
去年
Axovia Therapeutics Advances Gene Therapy for Bardet-Biedl Syndrome Blindness with Promising Preclinical Data
上个月
11-Year-Old Becomes First UK Patient to Receive Gene Therapy for Bardet-Biedl Syndrome Blindness
2年前
FDA Grants Priority Review for Setmelanotide sNDA in Young Children with Rare Genetic Obesity
去年
A Race Against Blindness Awards $1 Million to Advance AXV-101 Gene Therapy for Childhood Blindness
10个月前
Rhythm Pharmaceuticals Secures Public Reimbursement for IMCIVREE in Five Canadian Provinces
去年
Setmelanotide Shows Promise in Reducing Obesity in Young Children with Rare Genetic Deficiencies
10个月前
Rhythm Pharmaceuticals Reports Strong Q3 2025 Results with $51.3M IMCIVREE Revenue and December FDA Decision Pending
去年
Setmelanotide Shows Promise in Reducing Obesity in Young Children With Rare Genetic Deficiencies
去年
Rhythm Pharmaceuticals Reports Strong Q3 2024 Driven by IMCIVREE Sales, Advances Hypothalamic Obesity Program
去年
Rhythm Pharmaceuticals Regains Global Control of IMCIVREE by Reacquiring Rights in China
第 1 页,共 17 页
上一页
下一页